Lv51
870 积分 2023-09-12 加入
Five-year real-world drug survival of dupilumab in severe atopic dermatitis and associate predictors
5小时前
待确认
Bemarituzumab in patients with FGFR2b-selected gastric or gastro-oesophageal junction adenocarcinoma (FIGHT): a randomised, double-blind, placebo-controlled, phase 2 study
1个月前
已完结
Glucagon-like peptide 1 receptor agonists and the potential risk of pancreatic carcinoma: a pharmacovigilance study using the FDA Adverse Event Reporting System and literature visualization analysis
9个月前
已完结
度拉糖肽和达格列净分别联合二甲双胍治疗2型糖尿病并高尿酸血症
1年前
已完结
基于OpenFDA挖掘与评价司美格鲁肽上市后的不良反应
1年前
已完结
Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study
1年前
已完结
In type 1 diabetes, weekly basal insulin Fc was noninferior to daily insulin degludec for HbA1c at 26 wk
1年前
已完结
Glycaemic control, risk of hypoglycaemia and all-cause mortality in new users of second-generation basal insulin with type 2 diabetes and chronic kidney disease: a nationwide register-based cohort study
1年前
已完结
Switching to once-weekly insulin icodec versus once-daily insulin degludec in individuals with basal insulin-treated type 2 diabetes (ONWARDS 2): a phase 3a, randomised, open label, multicentre, treat-to-target trial
1年前
已完结
Switching to once-weekly insulin icodec versus once-daily insulin degludec in individuals with basal insulin-treated type 2 diabetes (ONWARDS 2): a phase 3a, randomised, open label, multicentre, treat-to-target trial
1年前
已完结
皖公网安备34019202002308
